Investigational Drug Information for Bicifadine
✉ Email this page to a colleague
What is the development status for investigational drug Bicifadine?
Bicifadine is an investigational drug.
There have been 5 clinical trials for Bicifadine.
The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2004.
The most common disease conditions in clinical trials are Back Pain, Low Back Pain, and Peripheral Nervous System Diseases. The leading clinical trial sponsors are DOV Pharmaceutical, Inc., XTL Biopharmaceuticals, and [disabled in preview].
Summary for Bicifadine
US Patents | 0 |
International Patents | 0 |
US Patent Applications | 564 |
WIPO Patent Applications | 270 |
Japanese Patent Applications | 7 |
Clinical Trial Progress | Phase 3 (2004-12-01) |
Vendors | 34 |
Recent Clinical Trials for Bicifadine
Title | Sponsor | Phase |
---|---|---|
A 52-Week Study of Bicifadine in Patients With Chronic Neuropathic Pain Associated With Diabetic Peripheral Neuropathy | XTL Biopharmaceuticals | Phase 2 |
Double Blind RCT of Bicifadine SR in Outpatients With Chronic Neuropathic Pain Associated With Diabetes | XTL Biopharmaceuticals | Phase 2 |
Efficacy and Safety of Bicifadine in the Treatment of Chronic Low Back Pain | DOV Pharmaceutical, Inc. | Phase 3 |
Clinical Trial Summary for Bicifadine
Top disease conditions for Bicifadine
Top clinical trial sponsors for Bicifadine
US Patents for Bicifadine
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |